Literature DB >> 29440351

Th1, Th17, and Th1Th17 Lymphocytes during Tuberculosis: Th1 Lymphocytes Predominate and Appear as Low-Differentiated CXCR3+CCR6+ Cells in the Blood and Highly Differentiated CXCR3+/-CCR6- Cells in the Lungs.

Irina Yu Nikitina1, Alexander V Panteleev1, George A Kosmiadi1, Yana V Serdyuk1, Tatiana A Nenasheva1, Alexander A Nikolaev1, Lubov A Gorelova1, Tatiana V Radaeva1, Yana Yu Kiseleva2, Vladimir K Bozhenko2, Irina V Lyadova3.   

Abstract

Th1 lymphocytes are considered the main mediators of protection against tuberculosis (TB); however, their phenotypic characteristics and relationship with Th17 and Th1Th17 populations during TB are poorly understood. We have analyzed Th1, Th17, and Th1Th17 lymphocytes in the blood and pulmonary lesions of TB patients. The populations were identified based on the production of IFN-γ and/or IL-17 and the coexpression of CXCR3 (X3) and CCR6 (R6). In the blood, IL-17+ and IFN-γ+IL-17+ lymphocytes were barely detectable (median, <0.01% of CD4+ lymphocytes), whereas IFN-γ+ lymphocytes predominated (median, 0.45%). Most IFN-γ+ lymphocytes (52%) were X3+R6+, suggesting their "nonclassical" (ex-Th17) nature. In the lungs, IL-17+ and IFN-γ+IL-17+ lymphocytes were more frequent (0.3%, p < 0.005), yet IFN-γ+ cells predominated (11%). Phenotypically, lung CD4+ cells were X3+/loR6- The degree of differentiation of blood effector CD4+ lymphocytes (evaluated based on CD62L/CD27/CD28 coexpression) increased as follows: X3+R6+ < X3+R6- < X3-R6-, with X3-R6- cells being largely terminally differentiated CD62L-CD27-CD28- cells. Lung CD4+ lymphocytes were highly differentiated, recalling blood X3+/-R6- populations. Following in vitro stimulation with anti-CD3/anti-CD28 Abs, X3+R6+CD4+ lymphocytes converted into X3+R6- and X3-R6- cells. The results demonstrate that, during active TB, Th1 lymphocytes predominate in blood and lungs, document differences in X3/R6 expression by blood and lung CD4+ cells, and link the pattern of X3/R6 expression with the degree of cell differentiation. These findings add to the understanding of immune mechanisms operating during TB and are relevant for the development of better strategies to control it.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29440351     DOI: 10.4049/jimmunol.1701424

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  Moving tuberculosis vaccines from theory to practice.

Authors:  Peter Andersen; Thomas J Scriba
Journal:  Nat Rev Immunol       Date:  2019-09       Impact factor: 53.106

2.  Functional Analysis of Immune Signature Genes in Th1* Memory Cells Links ISOC1 and Pyrimidine Metabolism to IFN-γ and IL-17 Production.

Authors:  Yulia Kushnareva; Ian T Mathews; Alexander Y Andreyev; Gokmen Altay; Cecilia S Lindestam Arlehamn; Vijayanand Pandurangan; Roland Nilsson; Mohit Jain; Alessandro Sette; Bjoern Peters; Sonia Sharma
Journal:  J Immunol       Date:  2021-02-05       Impact factor: 5.422

3.  Tissue-resident-like CD4+ T cells secreting IL-17 control Mycobacterium tuberculosis in the human lung.

Authors:  Paul Ogongo; Liku B Tezera; Amanda Ardain; Shepherd Nhamoyebonde; Duran Ramsuran; Alveera Singh; Abigail Ng'oepe; Farina Karim; Taryn Naidoo; Khadija Khan; Kaylesh J Dullabh; Michael Fehlings; Boon Heng Lee; Alessandra Nardin; Cecilia S Lindestam Arlehamn; Alessandro Sette; Samuel M Behar; Adrie Jc Steyn; Rajhmun Madansein; Henrik N Kløverpris; Paul T Elkington; Alasdair Leslie
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 19.456

4.  High-Dimensional Profiling Reveals Heterogeneity of the Th17 Subset and Its Association With Systemic Immunomodulatory Treatment in Non-infectious Uveitis.

Authors:  Fleurieke H Verhagen; Sanne Hiddingh; Rianne Rijken; Aridaman Pandit; Emmerik Leijten; Michel Olde Nordkamp; Ninette H Ten Dam-van Loon; Stefan Nierkens; Saskia M Imhof; Joke H de Boer; Timothy R D J Radstake; Jonas J W Kuiper
Journal:  Front Immunol       Date:  2018-10-31       Impact factor: 7.561

Review 5.  Cell Differentiation Degree as a Factor Determining the Role for Different T-Helper Populations in Tuberculosis Protection.

Authors:  Irina Lyadova; Irina Nikitina
Journal:  Front Immunol       Date:  2019-05-08       Impact factor: 7.561

6.  Site-Specific DC Surface Signatures Influence CD4+ T Cell Co-stimulation and Lung-Homing.

Authors:  David Pejoski; Marie Ballester; Floriane Auderset; Maria Vono; Dennis Christensen; Peter Andersen; Paul-Henri Lambert; Claire-Anne Siegrist
Journal:  Front Immunol       Date:  2019-07-18       Impact factor: 7.561

Review 7.  Targeting Unconventional Host Components for Vaccination-Induced Protection Against TB.

Authors:  Elisa Nemes; Shabaana A Khader; Rosemary V Swanson; Willem A Hanekom
Journal:  Front Immunol       Date:  2020-07-24       Impact factor: 7.561

8.  CRID3, a blocker of apoptosis associated speck like protein containing a card, ameliorates murine spinal cord injury by improving local immune microenvironment.

Authors:  Yu-Qing Chen; Sai-Nan Wang; Yu-Jiao Shi; Jing Chen; Shu-Qin Ding; Jie Tang; Lin Shen; Rui Wang; Hai Ding; Jian-Guo Hu; He-Zuo Lü
Journal:  J Neuroinflammation       Date:  2020-08-29       Impact factor: 8.322

9.  GABAergic signaling linked to autophagy enhances host protection against intracellular bacterial infections.

Authors:  Jin Kyung Kim; Yi Sak Kim; Hye-Mi Lee; Hyo Sun Jin; Chiranjivi Neupane; Sup Kim; Sang-Hee Lee; Jung-Joon Min; Miwa Sasai; Jae-Ho Jeong; Seong-Kyu Choe; Jin-Man Kim; Masahiro Yamamoto; Hyon E Choy; Jin Bong Park; Eun-Kyeong Jo
Journal:  Nat Commun       Date:  2018-10-10       Impact factor: 14.919

Review 10.  Towards new TB vaccines.

Authors:  Benedict Brazier; Helen McShane
Journal:  Semin Immunopathol       Date:  2020-03-18       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.